Uncategorised - European Medical Journal

Continue
1 Mins
31 Jul 2018

Treating Rheumatoid Arthritis to Target: Is Low Disease Activity Good Enough?

Treat-to-target principles in rheumatoid arthritis (RA) are now widely recognised as effective in achieving optimal disease outcomes. This study examined…
9 Mins
31 Jul 2018

Anti-TNF in Rheumatic Diseases: Inventory and Outlook

With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…
13 Mins
31 Jul 2018

Review of the 19th European League Against Rheumatology Congress 2018

Almost 20 years have passed since the first annual European League Against Rheumatism (EULAR) Congress took place on the sunny shores of the French…
2 Mins
31 Jul 2018

Physician Global Assessments for Disease Activity in Rheumatoid Arthritis Are All Over the Map!

There have been many studies about patient global assessments of disease activity in rheumatoid arthritis (RA) and how these differ from physician global…
8 Mins
31 Jul 2018

Editor's Pick: JAK Inhibitors in the Treatment Algorithm of Rheumatoid Arthritis: A Review

Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…
4 Mins
31 Jul 2018

Congress Feature from EULAR 2018

Building on last year’s launch, the EULAR ‘Don’t Delay, Connect Today’ campaign was a highlight of this year’s EULAR Congress. As part of EMJ’s…
10 Mins
31 Jul 2018

Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge

Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…
1 Mins
31 Jul 2018

Linking Systemic Angiogenic Markers to Synovial Vascularisation in Rheumatoid Arthritis

The synovium is the primary site of the rheumatoid arthritis (RA)-related inflammatory process. One of the most noticeable signs of synovitis is the…
9 Mins
31 Jul 2018

Primary Sjögren’s Syndrome in the Elderly: Does Age of Onset Make a Difference?

Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases
2 Mins
31 Jul 2018

Development and Implementation of an Educational Video That Instructs Patients with Rheumatoid Arthritis for Self-Assessment of Disease Activity: Methodology of the AUTO-DAS in Middle Eastern Arab Countries Study

The treat-to-target concept has revolutionised rheumatoid arthritis (RA) management and prognosis. Using a specific treatment target, such as Disease…
We’ve noticed you’re accessing
from North/South America.